BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31753109)

  • 1. Surgical Considerations and Systemic Therapy of Melanoma.
    Gamboa AC; Lowe M; Yushak ML; Delman KA
    Surg Clin North Am; 2020 Feb; 100(1):141-159. PubMed ID: 31753109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Treatment of Melanoma: Recent Developments and Future Perspectives.
    Testori AAE; Ribero S; Indini A; MandalĂ  M
    Am J Clin Dermatol; 2019 Dec; 20(6):817-827. PubMed ID: 31177507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
    Pelster MS; Amaria RN
    Curr Treat Options Oncol; 2020 Feb; 21(2):10. PubMed ID: 32025932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma.
    McKean MA; Amaria RN
    Am J Clin Dermatol; 2018 Oct; 19(5):639-646. PubMed ID: 30039289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant and Neoadjuvant Therapies in Cutaneous Melanoma.
    Ponto J; Bell RB
    Oral Maxillofac Surg Clin North Am; 2022 May; 34(2):315-324. PubMed ID: 35491081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Surgery in Combination with Immunotherapy.
    Klemen ND; Shindorf ML; Sherry RM
    Surg Oncol Clin N Am; 2019 Jul; 28(3):481-487. PubMed ID: 31079801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy for malignant melanoma].
    Zaremba A; Zimmer L; Griewank KG; Ugurel S; Roesch A; Schadendorf D; Livingstone E
    Internist (Berl); 2020 Jul; 61(7):669-675. PubMed ID: 32462249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial immunotherapy for melanoma.
    George DD; Armenio VA; Katz SC
    Cancer Gene Ther; 2017 Mar; 24(3):141-147. PubMed ID: 27834353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Melanoma - A Review of Systemic Therapies.
    Lee KA; Nathan P
    Acta Derm Venereol; 2020 Jun; 100(11):adv00141. PubMed ID: 32346745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finding the right combination for neoadjuvant therapy in high-risk, stage III melanoma.
    Amaria R; Caffrey M
    Am J Manag Care; 2019 Feb; 25(2 Spec No.):SP43-SP44. PubMed ID: 30776211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adjuvant and palliative therapy of melanoma. Current status].
    Tilgen W
    Chirurg; 1994 Mar; 65(3):153-63. PubMed ID: 7514966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy.
    McKean MA; Amaria RN
    Cancer Treat Rev; 2018 Nov; 70():144-153. PubMed ID: 30195813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling melanoma by adjuvant therapy: why, whom and how?
    Schilling B; Wiesner T
    Br J Dermatol; 2019 Jan; 180(1):1-2. PubMed ID: 30604551
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant use of ipilimumab in locally advanced melanoma.
    Howie LJ; Tyler DS; Salama AK
    J Surg Oncol; 2015 Dec; 112(8):841-3. PubMed ID: 26768512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of melanoma: an historic overview of a field in transition.
    Gorantla VC; Kirkwood JM
    Hematol Oncol Clin North Am; 2014 Jun; 28(3):415-35. PubMed ID: 24880939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Changes and Innovations in Melanoma Treatment: A Review.
    Sabag N; Yakobson A; Silberstein E
    Isr Med Assoc J; 2020 Nov; 11(22):704-710. PubMed ID: 33249792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emerging Role of Surgery for Patients With Advanced Melanoma Treated With Immunotherapy.
    Puza CJ; Bressler ES; Terando AM; Howard JH; Brown MC; Hanks B; Salama AKS; Beasley GM
    J Surg Res; 2019 Apr; 236():209-215. PubMed ID: 30694757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Neo)adjuvant systemic therapy for melanoma.
    van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
    Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and planned multicenter trials for patients with primary or metastatic melanoma.
    Sondak VK; Han D; Deneve J; Kudchadkar R
    J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological complete response after neoadjuvant pembrolizumab and radiation.
    Mynard JN; Conry RM; De Los Santos J; Gordetsky JB; Contreras CM
    Clin Exp Dermatol; 2019 Jul; 44(5):570-573. PubMed ID: 30402885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.